Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Loo

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Journal of Medicinal Chemistry|February 7, 2001
Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functionsJ B Smaill, G W Rewcastle, J A Loo, et al.
Bioorganic & Medicinal Chemistry|June 1, 1997
Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcriptionH Y Mei, D P Mack, A A Galan, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
2,2'-Dithiobisbenzamides derived from alpha-, beta- and gamma-amino acids possessing anti-HIV activities: synthesis and structure-activity relationshipJ V Prasad, J A Loo, F E Boyer, et al.
Biochemistry|November 4, 1998
Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigasR Newcomb, B Szoke, A Palma, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitorD W Fry, A J Bridges, W A Denny, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Journal of Medicinal Chemistry|February 7, 2001
Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functionsJ B Smaill, G W Rewcastle, J A Loo, et al.
Bioorganic & Medicinal Chemistry|June 1, 1997
Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcriptionH Y Mei, D P Mack, A A Galan, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
2,2'-Dithiobisbenzamides derived from alpha-, beta- and gamma-amino acids possessing anti-HIV activities: synthesis and structure-activity relationshipJ V Prasad, J A Loo, F E Boyer, et al.
Biochemistry|November 4, 1998
Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigasR Newcomb, B Szoke, A Palma, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitorD W Fry, A J Bridges, W A Denny, et al.
Pageof 6